Compare NRSN & FEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRSN | FEBO |
|---|---|---|
| Founded | 2017 | 1993 |
| Country | Israel | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 7.4M |
| IPO Year | 2021 | 2022 |
| Metric | NRSN | FEBO |
|---|---|---|
| Price | $1.44 | $0.68 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $91.75 | N/A |
| AVG Volume (30 Days) | ★ 36.8K | 4.8K |
| Earning Date | 09-25-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.25 | $0.61 |
| 52 Week High | $7.50 | $1.46 |
| Indicator | NRSN | FEBO |
|---|---|---|
| Relative Strength Index (RSI) | 31.32 | 52.95 |
| Support Level | $0.61 | $0.65 |
| Resistance Level | $7.50 | $0.80 |
| Average True Range (ATR) | 0.33 | 0.08 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 24.85 | 70.51 |
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances, principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.